Pharma Aids Statistics

Total Valuation

Pharma Aids has a market cap or net worth of BDT 1.94 billion. The enterprise value is 1.93 billion.

Market Cap	1.94B
Enterprise Value	1.93B

Important Dates

The last earnings date was Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	Dec 8, 2024

Share Statistics

Pharma Aids has 3.12 million shares outstanding. The number of shares has increased by 0.21% in one year.

Current Share Class	n/a
Shares Outstanding	3.12M
Shares Change (YoY)	+0.21%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	23.57%
Owned by Institutions (%)	n/a
Float	2.36M

Valuation Ratios

The trailing PE ratio is 28.86.

PE Ratio	28.86
Forward PE	n/a
PS Ratio	4.51
PB Ratio	5.39
P/TBV Ratio	n/a
P/FCF Ratio	162.90
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.74, with an EV/FCF ratio of 161.85.

EV / Earnings	28.67
EV / Sales	4.48
EV / EBITDA	19.74
EV / EBIT	21.21
EV / FCF	161.85

Financial Position

The company has a current ratio of 3.01, with a Debt / Equity ratio of 0.06.

Current Ratio	3.01
Quick Ratio	1.32
Debt / Equity	0.06
Debt / EBITDA	0.21
Debt / FCF	1.69
Interest Coverage	231.62

Financial Efficiency

Return on equity (ROE) is 20.52% and return on invested capital (ROIC) is 16.34%.

Return on Equity (ROE)	20.52%
Return on Assets (ROA)	12.39%
Return on Capital (ROIC)	16.34%
Revenue Per Employee	5.46M
Profits Per Employee	852,862
Employee Count	79
Asset Turnover	0.94
Inventory Turnover	4.55

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.18%
50-Day Moving Average	655.26
200-Day Moving Average	677.42
Relative Strength Index (RSI)	45.92
Average Volume (20 Days)	45,511

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Aids had revenue of BDT 431.12 million and earned 67.38 million in profits. Earnings per share was 21.59.

Revenue	431.12M
Gross Profit	137.10M
Operating Income	91.07M
Pretax Income	91.93M
Net Income	67.38M
EBITDA	97.84M
EBIT	91.07M
Earnings Per Share (EPS)	21.59

Full Income Statement

Balance Sheet

The company has 32.69 million in cash and 20.21 million in debt, giving a net cash position of 12.48 million or 4.00 per share.

Cash & Cash Equivalents	32.69M
Total Debt	20.21M
Net Cash	12.48M
Net Cash Per Share	4.00
Equity (Book Value)	360.43M
Book Value Per Share	115.52
Working Capital	300.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.88 million and capital expenditures -1.95 million, giving a free cash flow of 11.94 million.

Operating Cash Flow	13.88M
Capital Expenditures	-1.95M
Free Cash Flow	11.94M
FCF Per Share	3.83

Full Cash Flow Statement

Margins

Gross margin is 31.80%, with operating and profit margins of 21.12% and 15.63%.

Gross Margin	31.80%
Operating Margin	21.12%
Pretax Margin	21.32%
Profit Margin	15.63%
EBITDA Margin	22.69%
EBIT Margin	21.12%
FCF Margin	2.77%

Dividends & Yields

This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.40%.

Dividend Per Share	2.50
Dividend Yield	0.40%
Dividend Growth (YoY)	-80.00%
Years of Dividend Growth	n/a
Payout Ratio	4.87%
Buyback Yield	-0.21%
Shareholder Yield	0.19%
Earnings Yield	3.46%
FCF Yield	0.61%

Dividend Details

Stock Splits

The last stock split was on December 4, 2011. It was a forward split with a ratio of 10.

Last Split Date	Dec 4, 2011
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a